Coronary artery disease (CAD) is a major public health concern. According to a report from the American Heart Association in 2021, an estimated 18.2 million adult Americans have CAD. CAD is responsible for 1 in every 7 deaths in the United States. Cardiac magnetic resonance (CMR) quantitative myocardial first-pass perfusion imaging is a non-invasive and non-ionizing technique for diagnosing CAD which provides an accurate assessment of myocardial ischemia and a comprehensive evaluation of myocardial function and infarction.
Despite multiple potential advantages of CMR perfusion imaging, current clinically available techniques have limited in-plane spatial resolution (~2-3 mm) and incomplete heart coverage, which impede the assessment of transmural perfusion differences and underestimate the extent of ischemia. With higher spatial resolution, there is an increased ability to detect transmural perfusion differences between the epicardium and the endocardium, which could improve the ability to detecting obstructive CAD.
We aim to develop fast and high-resolution quantitative perfusion imaging techniques with whole-heart coverage. Specifically, we have demonstrated excellent performances utilizing variable density spiral trajectories, parallel imaging, compressed sensing, outer volume suppression (OVS) and simultaneous multi-slice (SMS) techniques.